Thanks BK. He did not fully answer the question about Brilacidin fast-track. Either:
A. They haven't applied yet and are waiting to do so depending on the FDA meeting outcome and the FDA's posture B. They applied within the last 59 days and are awaiting word C. They applied and got denied.
His non-response is disappointing, but perhaps it's smart not to announce application for fast-track, in case it gets denied. Any informed opinions out there?